Life science industry boosting local investment to avert supply chain risk: Willis
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Life science industry boosting local investment to avert supply chain risk: Willis

John Hewitt Jones
April 05, 2021
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
Warehouse interior at sunset medicine getty.jpg

Risk managers in the life science industry are focusing on opportunities for local investment because of supply chain concerns raised by the Covid-19 pandemic, according to Willis Towers Watson.

According to the broker, companies in the sector are boosting regional production resources to mitigate the risks associated with relying on a single region for supply.

Pharmaceutical

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business
Take a free trial Already a subscriber? Login now

Topics

NewsBrokersWTW
JJ
John Hewitt Jones
Gift this article